查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1798029

2032年卵子冷冻和胚胎库市场预测：按服务类型、储存方式、年龄层、技术、应用、最终用户和地区进行的全球分析

Egg Freezing and Embryo Banking Market Forecasts to 2032 - Global Analysis By Service Type, Preservation Method, Age Group, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球卵子冷冻和胚胎银行市场规模预计在 2025 年达到 53.7 亿美元，到 2032 年将达到 117 亿美元，预测期内复合年增长率为 11.8%。

女性成熟的卵子被取出、冷冻并储存，以提高其日后受孕的几率，这项生育力保存技术被称为卵子冷冻（也称为卵子冷冻保存）。卵巢刺激、卵子取出以及透过玻璃化冷冻快速冷冻，用于保存细胞的完整性。在实验室环境下，透过卵子和精子受精，通常透过体外受精 (IVF) 来创造、冷冻和储存胚胎的过程被称为胚胎银行。这些技术为个人和夫妇提供了生育灵活性，有助于在老龄化或接受治疗之前保持生育能力，并可用于医疗、社会或个人目的。

根据欧洲人类生殖与胚胎学会的数据，全球每年实施的辅助生殖技术（ART）手术超过300万例。因此，随着ART手术的普及，短期供应的需求也随之成长。

不孕症问题日益严重，医学原因日益突出

由于压力、推迟生育计画以及生活方式的改变，不孕症率不断上升，导致对生育力保存服务的需求日益增长。许多人选择冷冻卵子，以防止因老龄化增长而导致的生育力下降。患有癌症、子宫内膜异位症和遗传性疾病等疾病的患者也被鼓励在接受可能影响生育力的治疗之前储存卵子或胚胎。生殖技术的进步正在提高这些程序的可及性和有效性。这些因素的综合作用将显着加速市场扩大和普及的速度。

高成本和负担能力问题

手术涉及昂贵的治疗、药物和储存费用。许多人，尤其是在中低收入地区，无法负担这些服务。有限的保险保障进一步加重了经济负担。因此，潜在用户会延后或避免生育力保存方案。这限制了市场成长，并限制了获得高级生殖保健服务的机会。

意识和接受度不断提高

当人们充分了解生殖保健知识时，他们更有可能考虑这种可能性。社会认可度可以减少耻辱感，使更多人更容易获得生育治疗。媒体的关注和医疗保健提供者的宣传活动进一步凸显了生育治疗的益处。提供此类福利的雇主接受度的提高也促进了人们的接受度。总体而言，认知度和接受度推动了市场成长和基本客群的扩大。

基础设施和访问限制

许多地区缺乏现代化的生育诊所和专业的储存设施。缺乏合格的医务人员降低了服务品质和范围。冷冻保存设备和实验室的高昂推出成本限制了其扩张。患者难以前往偏远地区的医疗机构。这些障碍限制了市场渗透，并阻碍了其广泛应用。

COVID-19的影响

新冠疫情严重扰乱了卵子冷冻和胚胎库市场，诊所关闭和旅行限制导致生育治疗延误。择期手术延后，服务需求暂时减少。供应链中断影响了医疗设备和用品的供应。然而，随着生殖健康意识的增强，加上对怀孕延迟的担忧，疫情过后人们对生育治疗的兴趣有所提升。远端医疗咨询的实施有助于维持与病患的关係，诊所也调整并加强了安全通讯协定，以有效率地恢復业务。

预测期内玻璃化固化细分市场预计将占最大份额

预计玻璃化冷冻技术将在预测期内占据最大的市场占有率，因为它能够快速冷冻，防止冰晶形成，从而提高细胞活力。这项先进技术提高了卵子和胚胎解冻后的存活率，从而增加了成功受精和怀孕的几率。其高效性和可靠性使其成为生育诊所和患者的首选方法。其较短的处理时间也降低了营运成本并改善了临床工作流程。玻璃化冷冻技术的认知度和应用日益增长，正在推动全球市场的成长。

预计冷冻库部分将在预测期内实现最高的复合年增长率

由于先进的储存设施，生殖材料能够长期保存，预计冷冻库细分市场将在预测期内实现最高成长率。冷冻库提供安全、温控的环境，能够长期维持卵子和胚胎的活力和品质。冷冻库也透过与生殖诊所合作，提供便利的取卵服务，扩大了服务的可近性。冷冻库冷冻保存方法的技术进步正在提高解冻后的存活率，并提高辅助生殖治疗的成功率。

占比最高的地区

预计北美地区将在预测期内占据最大的市场占有率，这得益于人们对不孕症的高度认知、雇主资助的社会福利以及发达的医疗保健基础设施。为了职业或教育而推迟生育的普遍趋势，以及大公司提供的卵子冷冻保险，也在显着加速冷冻技术的普及。技术优势包括玻璃化冷冻作为标准的冷冻保存方法、延时成像、人工智慧辅助胚胎选择以及整合到大型诊所的胚胎着床前基因检测系统。雇主和保险公司在资助这些服务、降低成本障碍和扩大不孕症治疗的可近性方面发挥关键作用。

复合年增长率最高的地区

由于不孕症盛行率上升、可支配收入增加以及中国、印度、日本和韩国等国家都市区女性劳动力规模不断扩大，预计亚太地区在预测期内的复合年增长率最高。东京的生育治疗津贴和澳洲扩大试管婴儿返利计画等国家倡议正在提高生育治疗的可及性和消费者意识。技术创新趋势包括超快速玻璃化冷冻、基于区块链的安全冷冻保存、跨境胚胎库的可扩展性，以及针对区域基因筛检和胚胎评估的人工智慧诊断工具。随着区域诊所提供经济高效且先进的生育治疗服务，医疗旅游业也加速成长。

提供免费客製化

订阅此报告的客户将获得以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场参与企业进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 透过产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球卵子冷冻及胚胎库市场（依服务类型）

  • 介绍
  • 冷冻卵子
  • 胚胎库
  • 其他的

6. 全球卵子冷冻及胚胎库市场（依储存方式）

  • 介绍
  • 慢速冷冻
  • 玻璃化冷冻

7. 全球卵子冷冻及胚胎库市场（依年龄层）

  • 介绍
  • 30岁以下
  • 30-39岁
  • 40岁或以上
  • 其他年龄段

8. 全球卵子冷冻及胚胎库市场（依技术）

  • 介绍
  • 体外受精（IVF）
  • 卵细胞质内单一精虫显微注射术（ICSI）
  • 其他的

9. 全球卵子冷冻及胚胎库市场（依应用）

  • 介绍
  • 医学生育力保存
  • 选择性生育力保存

第十章全球卵子冷冻和胚胎库市场（按最终用户）

  • 介绍
  • 不孕不育诊所
  • 医院
  • 冷冻库
  • 其他的

第 11 章。全球卵子冷冻和胚胎库市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • The Cooper Companies
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
  • Ferring Pharmaceuticals
  • Kindbody
  • Virtus Health Limited
  • Monash IVF Group
  • Progyny, Inc.
  • Shady Grove Fertility
  • Cryos International
  • California Cryobank
  • IVIRMA Global
  • FUJIFILM Irvine Scientific
  • Hamilton Thorne Ltd.
Product Code: SMRC30399

According to Stratistics MRC, the Global Egg Freezing and Embryo Banking Market is accounted for $5.37 billion in 2025 and is expected to reach $11.7 billion by 2032 growing at a CAGR of 11.8% during the forecast period. A woman's mature eggs are removed, frozen, and saved for later use in a fertility preservation procedure called egg freezing, also known as oocyte cryopreservation, which increases the likelihood of getting pregnant later in life. In order to preserve cell integrity, the procedure entails ovarian stimulation, egg removal, and quick freezing via vitrification. The process of creating, freezing, and storing embryos created by fertilizing eggs with sperm in a lab environment typically through in vitro fertilization (IVF) is known as embryo banking. These techniques, which give people or couples more reproductive flexibility and help, maintain fertility before ageing or medical treatments, are utilized for medical, social, or private reasons.

According to European Society of Human Reproduction and Embryology, more than 3 million ART cycles are performed annually across the world. Therefore, as the adoption of ART procedures expands so does the need for short term shortage.

Market Dynamics:

Driver:

Rising fertility concerns & medical reasons

The need for fertility preservation services has increased as a result of rising infertility rates brought on by stress, delayed family planning, and changes in lifestyle. As a preventative measure to preserve reproductive potential prior to age-related decline, many people choose to freeze their eggs. Before undertaking therapies that may affect fertility, patients with medical problems including cancer, endometriosis, or genetic diseases are also encouraged to preserve their eggs or embryos. Reproductive technology advancements have improved the accessibility and efficacy of these operations. When combined, these elements greatly accelerate the market's expansion and pace of adoption.

Restraint:

High costs & affordability issues

The procedures involve expensive medical treatments, medications, and storage fees. Many individuals, especially in low- and middle-income regions, cannot afford these services. Limited insurance coverage further increases the financial burden. As a result, potential users delay or avoid opting for fertility preservation. This restricts market growth and limits access to advanced reproductive options.

Opportunity:

Growing awareness & acceptance

People are more inclined to think about these possibilities sooner when they are well informed about reproductive health. As stigma is lessened by social acceptability, more people are becoming receptive to fertility preservation. The advantages are further emphasized by media attention and healthcare provider campaigns. Adoption is also aided by growing acceptance among employers who provide these perks. In general, market growth and client base expansion are being facilitated by awareness and acceptance.

Threat:

Infrastructure & access limitations

Modern fertility clinics and specialised storage facilities are scarce in many areas. The quality and scope of services are diminished by the scarcity of qualified medical personnel. Expansion is limited by the high startup costs for cryopreservation equipment and labs. Patients have trouble getting to healthcare facilities in isolated places. These obstacles restrict market penetration and impede adoption.

Covid-19 Impact:

The Covid 19 pandemic significantly disrupted the Egg Freezing and Embryo Banking Market, causing delays in fertility treatments due to clinic closures and travel restrictions. Elective procedures were postponed, leading to a temporary decline in service demand. Supply chain interruptions affected the availability of medical equipment and consumables. However, increased awareness of reproductive health, coupled with concerns over delayed pregnancies, boosted interest in fertility preservation post pandemic. Telemedicine adoption and digital consultations helped sustain patient engagement, while clinics adapted with enhanced safety protocols to resume operations efficiently.

The vitrification segment is expected to be the largest during the forecast period

The vitrification segment is expected to account for the largest market share during the forecast period by offering a rapid-freezing process that prevents ice crystal formation, ensuring higher cell survival rates. This advanced technique improves post-thaw viability of eggs and embryos, increasing the chances of successful fertilization and pregnancy. Its efficiency and reliability make it a preferred method among fertility clinics and patients. The shorter processing time also reduces operational costs and enhances clinical workflow. Growing awareness and adoption of vitrification technology are driving market growth globally.

The cryobanks segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cryobanks segment is predicted to witness the highest growth rate due to advanced storage facilities that ensure the long-term preservation of reproductive materials. They offer secure and temperature-controlled environments, maintaining the viability and quality of eggs and embryos for extended periods. Cryobanks also expand accessibility by partnering with fertility clinics and offering convenient retrieval services. Technological advancements in cryopreservation methods within cryobanks improve survival rates after thawing, enhancing success rates of fertility treatments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share is propelled by high fertility awareness, supportive employer sponsored benefits, and well developed healthcare infrastructure. The widespread trend of postponing parenthood for careers or education, combined with offers of egg freezing insurance by large corporations, also significantly accelerates adoption. Technological advantages include vitrification as the standard cryopreservation method, time-lapse imaging, AI driven embryo selection, and preimplantation genetic testing systems embedded in leading clinics. Employers and insurers play a key role by funding these services, reducing cost barriers, and widening access to fertility preservation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising infertility, increasing disposable incomes, and expanding urban female workforce participation in countries such as China, India, Japan, and South Korea. National government initiatives such as fertility subsidies in Tokyo and expanded IVF rebate programs in Australia-boost accessibility and consumer awareness. Innovation trends include ultra rapid vitrification, blockchain secured cry storage, scalability of embryo banks across borders, and AI based diagnostic tools tailored for local genetic screening and embryo assessment. Medical tourism also accelerates growth as regional clinics provide cost-effective, advanced fertility preservation services.

Key players in the market

Some of the key players in Egg Freezing and Embryo Banking Market include The Cooper Companies, Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, Ferring Pharmaceuticals, Kindbody, Virtus Health Limited, Monash IVF Group, Progyny, Inc., Shady Grove Fertility, Cryos International, California Cryobank, IVIRMA Global, FUJIFILM Irvine Scientific and Hamilton Thorne Ltd.

Key Developments:

In February 2025, Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry, a comprehensive real world clinical data platform. It aims to collect, analyze, and share longitudinal patient data to advance understanding, treatment development, and management strategies for autoimmune diseases.

In May 2024, Vitrolife AB acquired eFertility to integrate its eWitness tracking and eBase EMR systems, enabling secure, efficient, and standardized egg freezing and embryo banking workflows. This move strengthens Vitrolife's end to end IVF platform and advances its digital clinic management capabilities.

In May 2023, Thermo Fisher Scientific partnered with Pfizer to broaden access to lung and breast cancer testing, aiming to enhance early detection and personalized treatment. The collaboration focused on advanced diagnostic solutions, with no link to fertility preservation services.

Service Types Covered:

  • Egg Freezing
  • Embryo Banking
  • Other Service Types

Preservation Methods Covered:

  • Slow Freezing
  • Vitrification

Age Groups Covered:

  • <30 Years
  • 30-39 Years
  • >=40 Years
  • Other Age Groups

Technologies Covered:

  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Other Technologies

Applications Covered:

  • Medical Fertility Preservation
  • Elective Fertility Preservation

End Users Covered:

  • Fertility Clinics
  • Hospitals
  • Cryobanks
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Egg Freezing and Embryo Banking Market, By Service Type

  • 5.1 Introduction
  • 5.2 Egg Freezing
  • 5.3 Embryo Banking
  • 5.4 Other Service Types

6 Global Egg Freezing and Embryo Banking Market, By Preservation Method

  • 6.1 Introduction
  • 6.2 Slow Freezing
  • 6.3 Vitrification

7 Global Egg Freezing and Embryo Banking Market, By Age Group

  • 7.1 Introduction
  • 7.2 <30 Years
  • 7.3 30-39 Years
  • 7.4 >=40 Years
  • 7.5 Other Age Groups

8 Global Egg Freezing and Embryo Banking Market, By Technology

  • 8.1 Introduction
  • 8.2 In Vitro Fertilization (IVF)
  • 8.3 Intracytoplasmic Sperm Injection (ICSI)
  • 8.4 Other Technologies

9 Global Egg Freezing and Embryo Banking Market, By Application

  • 9.1 Introduction
  • 9.2 Medical Fertility Preservation
  • 9.3 Elective Fertility Preservation

10 Global Egg Freezing and Embryo Banking Market, By End User

  • 10.1 Introduction
  • 10.2 Fertility Clinics
  • 10.3 Hospitals
  • 10.4 Cryobanks
  • 10.5 Other End Users

11 Global Egg Freezing and Embryo Banking Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 The Cooper Companies
  • 13.2 Merck KGaA
  • 13.3 Thermo Fisher Scientific Inc.
  • 13.4 Vitrolife AB
  • 13.5 Ferring Pharmaceuticals
  • 13.6 Kindbody
  • 13.7 Virtus Health Limited
  • 13.8 Monash IVF Group
  • 13.9 Progyny, Inc.
  • 13.10 Shady Grove Fertility
  • 13.11 Cryos International
  • 13.12 California Cryobank
  • 13.13 IVIRMA Global
  • 13.14 FUJIFILM Irvine Scientific
  • 13.15 Hamilton Thorne Ltd.

List of Tables

  • Table 1 Global Egg Freezing and Embryo Banking Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 3 Global Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 4 Global Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 5 Global Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 6 Global Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 7 Global Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 8 Global Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 9 Global Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 10 Global Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 11 Global Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 12 Global Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 13 Global Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 14 Global Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 15 Global Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 16 Global Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 17 Global Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 18 Global Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 20 Global Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 21 Global Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 23 Global Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 24 Global Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 25 Global Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 26 North America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 27 North America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 28 North America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 29 North America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 30 North America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 31 North America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 32 North America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 33 North America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 34 North America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 35 North America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 36 North America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 37 North America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 38 North America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 39 North America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 40 North America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 41 North America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 42 North America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 43 North America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 44 North America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 45 North America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 46 North America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 47 North America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 48 North America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 49 North America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 50 North America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 51 Europe Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 52 Europe Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 53 Europe Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 54 Europe Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 55 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 56 Europe Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 57 Europe Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 58 Europe Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 59 Europe Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 60 Europe Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 61 Europe Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 62 Europe Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 63 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 64 Europe Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 65 Europe Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 66 Europe Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 67 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 68 Europe Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 69 Europe Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 70 Europe Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 71 Europe Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 72 Europe Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 73 Europe Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 74 Europe Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 75 Europe Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 76 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 77 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 78 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 79 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 80 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 81 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 82 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 83 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 84 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 85 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 86 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 87 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 88 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 89 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 90 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 91 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 92 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 93 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 94 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 95 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 96 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 97 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 98 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 99 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 100 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 101 South America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 102 South America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 103 South America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 104 South America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 105 South America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 106 South America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 107 South America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 108 South America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 109 South America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 110 South America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 111 South America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 112 South America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 113 South America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 114 South America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 115 South America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 116 South America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 117 South America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 118 South America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 119 South America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 120 South America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 121 South America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 122 South America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 123 South America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 124 South America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 125 South America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 126 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
  • Table 127 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
  • Table 128 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
  • Table 129 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
  • Table 130 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
  • Table 131 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 132 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
  • Table 133 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
  • Table 134 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 135 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
  • Table 136 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
  • Table 137 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
  • Table 138 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
  • Table 139 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 140 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
  • Table 141 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
  • Table 142 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 143 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
  • Table 144 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
  • Table 145 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
  • Table 146 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
  • Table 147 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
  • Table 148 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 149 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
  • Table 150 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)